Skip to main content

Advertisement

SpringerLink
Log in

Optimizing Lead Placement in Sacral Neuromodulation

  • Reconstructed Bladder Function & Dysfunction (M Kaufman, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Purpose of review

Sacral neuromodulation remains an effective therapy for multiple conditions and both the technology and implant techniques have evolved over more than two decades. Understanding of the ideal conditions for testing and administration of the therapy continue to progress as well, though considerable controversy still exists. This review seeks to clarify the current knowledge and opinion surrounding types of neuromodulation testing, what constitutes an optimized lead and best practices for maximizing therapeutic success.

Recent findings

There are distinct advantages and disadvantages to each method of sacral neuromodulation testing that should be individualized to each patient. While motor response during lead implantation may be more reliable and even necessary, an approach which balances both motor and sensory data may be advantageous. Optimized lead placement, though not conclusively proven to offer definite advantages, remains a laudable goal for most implantations.

Summary

Sacral neuromodulation remains an important therapy for patients with pelvic voiding and elimination dysfunction. Important considerations including office-based or staged testing, motor or sensory prioritization, and the importance of lead optimization remain debatable. However, there remain important lessons that can influence the likelihood of successful therapy. Although there is still work to be done, we are continuing to strive for improvement in patient outcomes as a result of optimized lead placement in sacral neuromodulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Liberman D, Ehlert MJ, Siegel SW. Sacral Neuromodulation in urological practice. Urology. 2017;99:14–22. https://doi.org/10.1016/j.urology.2016.06.004.

    Article  PubMed  Google Scholar 

  2. Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National community prevalence of overactive bladder in the United States stratified by sex and age. Urology. 2011;77(5):1081–7. https://doi.org/10.1016/j.urology.2010.08.039.

  3. Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019. J Urol. 2019;202(3):558–63. https://doi.org/10.1097/JU.0000000000000309.

    Article  PubMed  Google Scholar 

  4. Goldman HB, Lloyd JC, Noblett KL, Carey MP, Casta Ño-Botero JC, Gajewski JB, et al. International continence society best practice statement for use of sacral neuromodulation. Neurourol Urodyn. 2018;37(5):1821–2. https://doi.org/10.1002/nau.23596Consensus expert opinion on a range of issues surrounding sacral neuromodulation.

    Article  PubMed  Google Scholar 

  5. Liberman D, Ehlert MJ, Siegel SW. Optimizing outcomes of sacral neuromodulation for the treatment of urinary retention. Curr Bladder Dysfunct Rep. 2016;11:272–6. https://doi.org/10.1007/s11884-016-0373-4.

    Article  Google Scholar 

  6. Peters KM. Neuromodulation for the treatment of refractory interstitial cystitis. Rev Urol. 2002;4 Suppl 1(Suppl 1):S36–43.

    PubMed  Google Scholar 

  7. Bosch JL, Groen J. Sacral (S3) segmental nerve stimulation as a treatment for urge incontinence in patients with detrusor instability: results of chronic electrical stimulation using an implantable neural prosthesis. J Urol. 1995;154(2 Pt 1):504–7. https://doi.org/10.1097/00005392-199508000-00045.

    Article  CAS  PubMed  Google Scholar 

  8. Siegel SW, Catanzaro F, Dijkema HE, Elhilali MM, Fowler CJ, Gajewski JB, et al. Lycklama a Nijeholt AA, Oleson KA, Schmidt RA. Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. Urology. 2000;56(6 Suppl 1):87–91. https://doi.org/10.1016/s0090-4295(00)00597-5.

    Article  CAS  PubMed  Google Scholar 

  9. Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015;34(3):224–30. https://doi.org/10.1002/nau.22544.

    Article  PubMed  Google Scholar 

  10. Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, et al. Three-year follow-up results of a prospective, multicenter study in overactive bladder subjects treated with sacral neuromodulation. Urology. 2016;94:57–63. https://doi.org/10.1016/j.urology.2016.04.024.

    Article  PubMed  Google Scholar 

  11. Mellgren A, Wexner SD, Coller JA, Devroede G, Lerew DR, Madoff RD, et al. Long-term efficacy and safety of sacral nerve stimulation for fecal incontinence. Dis Colon Rectum. 2011;54(9):1065–75. https://doi.org/10.1097/DCR.0b013e31822155e9.

    Article  PubMed  Google Scholar 

  12. De Groat WC, Ryall RW. The identification and characteristics of sacral parasympathetic preganglionic neurones. J Physiol. 1968;196(3):563–77. https://doi.org/10.1113/jphysiol.1968.sp008523.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Noblett KL, Cadish LA. Sacral nerve stimulation for the treatment of refractory voiding and bowel dysfunction. Am J Obstet Gynecol. 2014;210(2):99–106. https://doi.org/10.1016/j.ajog.2013.07.025.

    Article  PubMed  Google Scholar 

  14. De Wachter S, Vaganee D, Kessler TM. Sacral neuromodulation: mechanism of action. Eur Urol Focus. 2020;6(5):823–5. https://doi.org/10.1016/j.euf.2019.11.018.

    Article  PubMed  Google Scholar 

  15. Gill BC, Pizarro-Berdichevsky J, Bhattacharyya PK, Brink TS, Marks BK, Quirouet A, et al. Real-time changes in brain activity during sacral neuromodulation for overactive bladder. J Urol. 2017;198(6):1379–85. https://doi.org/10.1016/j.juro.2017.06.074.

    Article  PubMed  Google Scholar 

  16. Banakhar M, Hassouna M. Percutaneous nerve evaluation test versus staged test trials for sacral neuromodulation: sensitivity, specificity, and predictive values of each technique. Int Neurourol J. 2016;20(3):250–4. https://doi.org/10.5213/inj.1630498.249.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Spinelli M, Sievert KD. Latest technologic and surgical developments in using InterStim therapy for sacral neuromodulation: impact on treatment success and safety. Eur Urol. 2008;54(6):1287–96. https://doi.org/10.1016/j.eururo.2008.01.076.

    Article  PubMed  Google Scholar 

  18. Everaert K, Kerckhaert W, Caluwaerts H, Audenaert M, Vereecke H, De Cuypere G, et al. A prospective randomized trial comparing the 1-stage with the 2-stage implantation of a pulse generator in patients with pelvic floor dysfunction selected for sacral nerve stimulation. Eur Urol. 2004 May;45(5):649–54. https://doi.org/10.1016/j.eururo.2003.11.015.

    Article  CAS  PubMed  Google Scholar 

  19. Borawski KM, Foster RT, Webster GD, Amundsen CL. Predicting implantation with a neuromodulator using two different test stimulation techniques: a prospective randomized study in urge incontinent women. Neurourol Urodyn. 2007;26(1):14–8. https://doi.org/10.1002/nau.20332.

    Article  PubMed  Google Scholar 

  20. Leong RK, De Wachter SG, Nieman FH, de Bie RA, van Kerrebroeck PE. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy. Neurourol Urodyn. 2011;30(7):1249–52. https://doi.org/10.1002/nau.20979.

    Article  PubMed  Google Scholar 

  21. Scheepens W, Van Koeveringe G, De Bie R, Weil E, Van Kerrebroeck P. Long-term efficacy and safety results of the two-stage implantation technique in sacral neuromodulation. BJU International. 2002;90:840–5. https://doi.org/10.1046/j.1464-410X.2002.03028.x.

    Article  CAS  PubMed  Google Scholar 

  22. El-Azab AS, Siegel SW. Specific tips for general controversies in sacral neuromodulation. Curr Urol Rep. 2016;17(11):79. https://doi.org/10.1007/s11934-016-0640-0.

    Article  PubMed  Google Scholar 

  23. Povo A, Arantes M, Matzel KE, Barbosa J, Ferreira MA, Pais D, et al. Surface anatomical landmarks for the location of posterior sacral foramina in sacral nerve stimulation. Tech Coloproctol. 2016;20(12):859–64. https://doi.org/10.1007/s10151-016-1543-2.

    Article  CAS  PubMed  Google Scholar 

  24. Williams ER, Siegel SW. Procedural techniques in sacral nerve modulation. Int Urogynecol J. 2010;21 Suppl 2:S453–60. https://doi.org/10.1007/s00192-010-1280-4A useful guide to optimized lead placement techniques.

    Article  PubMed  Google Scholar 

  25. Jairam R, Marcelissen T, van Koeveringe G, van Kerrebroeck P. Optimal lead positioning in sacral neuromodulation: which factors are related to treatment outcome? Neuromodulation. 2017;20(8):830–5. https://doi.org/10.1111/ner.12649.

    Article  PubMed  Google Scholar 

  26. Ghamarian P, Moskowitz D. Intraoperative tips and tricks for successful sacral neuromodulation. Current Bladder Dysfunction Reports. 2019;14:191–6. https://doi.org/10.1007/s11884-019-00522-x.

    Article  Google Scholar 

  27. Buchs NC, Dembe JC, Robert-Yap J, Roche B, Fasel J. Optimizing electrode implantation in sacral nerve stimulation—an anatomical cadaver study controlled by a laparoscopic camera. Int J Colorectal Dis. 2008;23(1):85–91. https://doi.org/10.1007/s00384-007-0367-y.

    Article  CAS  PubMed  Google Scholar 

  28. Crites-Bachert M, Clark C. Needle placement: a guide to predictable sensory and motor responses based on variations in needle placement during sacral neuromodulation procedures. Int Neurourol J. 2019;23(4):302–9. https://doi.org/10.5213/inj.1938088.044.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Matzel KE, Chartier-Kastler E, Knowles CH, Lehur PA, Muñoz-Duyos A, Ratto C, et al. Sacral neuromodulation: standardized electrode placement technique. Neuromodulation. 2017;20(8):816–24. https://doi.org/10.1111/ner.12695An excellent technical description of optimized lead placement techniques.

    Article  PubMed  Google Scholar 

  30. Gilleran JP, Killinger K, Boura J, Peters KM. Number of active electrodes at time of staged tined lead interstim implant does not impact clinical outcomes. Neurourol Urodyn. 2016;35(5):625–9. https://doi.org/10.1002/nau.22766An important finding challenging the accepted idea of the importance of lead optimization.

    Article  PubMed  Google Scholar 

  31. Pizarro-Berdichevsky J, Gill BC, Clifton M, Okafor HT, Faris AE, Vasavada SP, et al. Motor response matters: optimizing lead placement improves sacral neuromodulation outcomes. J Urol. 2018;199(4):1032–6. https://doi.org/10.1016/j.juro.2017.11.066An intriguing study looking at the relative importance of bellows vs toe response.

    Article  PubMed  Google Scholar 

  32. Marinkovic SP, Ford JC. Improving clinical outcomes for women with overactive bladder or urinary retention symptoms: a comparison of motor response voltages (1-9 V) during Stage 1 sacral neuromodulation. BJU Int. 2018;122(3):472–9. https://doi.org/10.1111/bju.14240.

    Article  PubMed  Google Scholar 

  33. Gurtner K, Couvaras A, Goudelocke CM. “Mixed” motor sacral modulation lead placement results in higher implant rates. SUFU Abstracts 2020. Neurourol Urodyn. 2020;39(S1):145 (recent).

    Google Scholar 

  34. Peters KM, Killinger KA, Boura JA. Is sensory testing during lead placement crucial for achieving positive outcomes after sacral neuromodulation? Neurourol Urodyn. 2011;30(8):1489–92. https://doi.org/10.1002/nau.21122.

    Article  PubMed  Google Scholar 

  35. Cohen BL, Tunuguntla HS, Gousse A. Predictors of success for first stage neuromodulation: motor versus sensory response. J Urol. 2006;175(6):2178–80; discussion 2180-1. https://doi.org/10.1016/S0022-5347(06)00315-6.

    Article  PubMed  Google Scholar 

  36. Lee J, Osann K, Noblett K. Comparison of motor and sensory response of InterStim® for overactive bladder syndrome. Female Pelvic Med Reconstr Surg. 2013;19(6):317–21. https://doi.org/10.1097/SPV.0b013e3182a2954e.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ochsner Health, 1004 Octavia Street, New Orleans, LA, 70115, USA

    Anastasia Couvaras & Colin Goudelocke

Authors
  1. Anastasia Couvaras
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Colin Goudelocke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Colin Goudelocke.

Ethics declarations

Conflict of Interest

Anastasia Couvaras declares that she has no conflict of interest. Colin Goudelocke has received research funding and speaker honorarium from Medtronic (Minneapolis, USA) .

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Reconstructed Bladder Function & Dysfunction

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Couvaras, A., Goudelocke, C. Optimizing Lead Placement in Sacral Neuromodulation. Curr Bladder Dysfunct Rep 16, 74–79 (2021). https://doi.org/10.1007/s11884-021-00634-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-021-00634-3

Keywords

Search

Navigation